Genix Pharmaceuticals (GENX) Financial Statements
Genix Pharmaceuticals Financial Overview
Genix Pharmaceuticals's market cap is currently $918.36K. The company's EPS TTM is ―; its P/E ratio is -3.00; Genix Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Oct 23 | Oct 22 | Oct 21 | Oct 20 | Oct 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 3.26K | ― | ― | ― | $ -45.69K |
| Operating Income | $ -880.89K | $ -1.03M | $ -1.65M | $ -715.21K | $ -143.34K |
| EBITDA | $ -3.80M | $ -497.69K | $ -1.11M | $ -353.21K | $ -162.67K |
| Net Income | $ -4.40M | $ -1.07M | $ -1.65M | $ -718.66K | $ -164.70K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 223.46K | $ 4.25M | $ 4.77M | $ 5.35M | $ 40.27K |
| Total Debt | $ 511.52K | $ 182.50K | $ 48.94K | $ 155.18K | $ 20.58K |
| Net Debt | $ 499.89K | $ 173.24K | $ -89.87K | $ -541.42K | $ -10.76K |
| Total Liabilities | $ 1.36M | $ 1.05M | $ 755.19K | $ 489.88K | $ 82.41K |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -220.67K | $ -222.92K | $ -428.31K | $ -195.03K | $ -58.55K |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD